Safety and Efficacy of Deoxycholate Treatment of Small Fatty Deformities ( SFD)

You may not qualify if:

• Patients who present with adipose tumors (lipoma)
• Human immunodeficiency virus (HIV)- or medication-related lipodystrophies
• Concurrent therapy that, in the investigator's opinion, would interfere with evaluation of the efficacy or safety of the medication.
• Active infection involving the fatty deformity zones.
• Pregnant women, nursing mothers, or women who are planning pregnancy during the study, or think they may be pregnant at the start of the study. Throughout the course of the study, women of childbearing potential must use reliable forms of contraception (e.g. abstinence, oral contraceptives for more than 12 consecutive weeks prior to enrollment, or spermicide and condoms).
• Current history of chronic drug or alcohol abuse.
• Clinically diagnosed anxiety disorder, or any other significant psychiatric disorder (e.g. depression) that, in the opinion of the investigator, might interfere with the patient's participation in the study.
• History of any intervention to treat cellulite (e.g., liposuction, surgery, laser, or lipolytic agents).
• History of trauma associated with the cellulite areas that in the judgment of the investigator may affect evaluation of safety or efficacy of treatment.
• Body mass index of \>40.0 as determined on Visit 1.
• A result on coagulation tests (PT, PTT) obtained within 28 days before randomization that indicates the presence of any clinically significant bleeding disorder.
• Any medical condition (e.g., respiratory, cardiovascular, hepatic, neurological disease, or thyroid dysfunction) that would interfere with assessment of safety or efficacy or compromise the subject's ability to undergo study procedures or give informed consent.
• Treatment with radio frequency or laser procedures in the cellulite zones within 12 months before randomization.
• History of sensitivity to any components of the study material
• History of sensitivity to topical or local anesthetics (e.g., lidocaine, benzocaine, procaine).
• +2 more criteria